Part D/Prescription Drugs – Page 2 – medicarereport.org

Saturday, December 13, 2025

Latest:

FDA Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook November 17, 2025November 17, 2025 Biosimilars drugs, FDA, Healthcare Costs, Healthcare Finance, Medicare Part D

FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office

(By Arthur Allen for KFF Health News) While the FDA is streamlining regulation of copycat versions of the expensive drugs

CMS Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook November 17, 2025November 17, 2025 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Part D, Older Adults

2026 Medicare Parts A & B Premiums and Deductibles

(Source – www.cms.gov) the Centers for Medicare & Medicaid Services (CMS) released the 2026 premiums, deductibles, and coinsurance amounts for

CMS Health Care Finance Health Insurance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook November 14, 2025November 14, 2025 CMS, Healthcare Costs, Healthcare Finance, Medicare Open enrollment, Medicare Part D, Older Adults, Provider Network

Don’t overlook provider network

We are currently in the Medicare Open Enrollment period, during which Medicare recipients can make changes to their Medicare coverage.

Consumer Data Health Care Finance Part D/Prescription Drugs

Eileen Cook November 14, 2025November 14, 2025 GLP-1 drugs, Healthcare Costs, Healthcare Finance

Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford

(Contact – Craig Palosky for The Kaiser Family Foundation published November 14, 2025) About one in eight adults (12%) say

CMS Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook November 12, 2025November 12, 2025 CMS, medicare, Medicare Advantage, Medicare Part D, Medigap, Older Adults

Before you sign up for a Medicare Advantage plan

Medicare Advantage health plans have experienced steady growth in recent years, and by 2025, they had reached 54 percent of

CMS Health Care Finance Health Care Redesign Legislative Update Medicare - General Part D/Prescription Drugs

Eileen Cook November 7, 2025November 7, 2025 CMS, Healthcare Costs, Healthcare Finance, Medicaid, medicare, Medicare Part D, Older Adults, Weight-loss drugs

Medicare will cover weight-loss drugs

Medicare will cover weight-loss drugs under a new deal with drugmakers Eli Lilly and Novo Nordisk. Approximately 10 percent of

CMS Dual Eligible Health Care Finance Medicaid Medicare Advantage Part D/Prescription Drugs

Eileen Cook November 4, 2025November 4, 2025 CMS, Medicaid, medicare, Medicare Advantage, Medicare Advantage Special Needs Plans, Medicare Part D, Older Adults

Are special needs plans the backbone of Medicare Advantage?

(By: Elizabeth Casolo for Becker’s Hospital Review) Special needs plans are far from new, but they continue to hold promise as

CMS Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook November 4, 2025November 4, 2025 CMS, medicare, Medicare Advantage, Medicare Open enrollment, Medicare Part D, Older Adults

What You Can Do If Your Medicare Advantage Insurer Leaves

Insurers are reducing the number of Medicare Advantage health plans offered in 2026. However, analysis from Investopedia found that the

FDA HHS Part D/Prescription Drugs

Eileen Cook November 3, 2025November 3, 2025 Biosimilars drugs, FDA, Healthcare Costs, Healthcare Finance, HHS

FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs

(Source – www.hhs.gov) WASHINGTON— OCTOBER 29, 2025 — The U.S. Food and Drug Administration (FDA) today announced significant action to

CMS Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook November 3, 2025November 3, 2025 CMS, Healthcare Costs, medicare, Medicare Advantage, Medicare Open enrollment, Medicare Part D, Older Adults

Where to start during Medicare open enrollment

The Medicare Open Enrollment Period for 2026 is from October 15 to December 7, 2025. During this time, beneficiaries can